Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sweden backs life sciences with $326m

This article was originally published in Scrip

Executive Summary

The Swedish government is to invest SEK11.49 billion ($1.75 billion) in research and innovation over the next four years, with SEK2.14 billion ($326 million) of that earmarked for life sciences. The prime minister Fredrik Reinfeldt announced details of the forthcoming research and innovation bill on a visit to SciLifeLab, a centre that brings together life science research from four Swedish universities, which is to see its funding doubled over the period.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC018733

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel